Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice
Sanmamed, M. F., Rodriguez, I., Schalper, K. A., … & Alfaro, C. (2015). Cancer research, 75(17), 3466-3478. doi: 10.1158/0008-5472.CAN-14-3510. PMID: 26113085.